informaworld logo
HOME . ABOUT US . CONTACT US 		HELP . PUBLISH WITH US . LIBRARIANS 
ebooks logo journals logo reference works logo abstract databases logo
bullet  SIGN IN Register | Why Register? | Got a Voucher? alerts   marked lists   shopping cart 
Advert: Informa Healthcare - http://www.informahealthcare.com

informaworld

HOME   |   SEARCH   |   BROWSE
    Issues List       Latest Issue       Forthcoming Articles       Volume 50 Issue 6       Aims & Scope       Editorial Board       Instructions for Authors       Subscribe      
<< earliestearliest   < prevprev   Issue listissues   next >next   latest >>latest
Publisher Logo Publication Cover
Search within this journal

Leukemia and Lymphoma, Volume 50 Issue 6 2009

Leukemia and Lymphoma is moving!
2008 Impact Factor: 1.939 (© Thomson Reuters, Journal Citation Reports®, 2009)
ISSN: 1029-2403 (electronic) 1042-8194 (paper)
Publication Frequency: 12 issues per year
Viewing the Journal: Select the initial letter of your research topic from the list below, or enter your search term on the left.
Sort by: Title | Page | Author
< Previous • 1 • 2 • Next >
View new articles ahead of the print edition
select-down Click for help
Commentaries
The many lives of thalidomide
Mehul P. Patel; Asher A. Chanan-Khan
Pages 861 – 862
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Management of autoimmune cytopenia complicating chronic lymphocytic leukemia
Clive S. Zent; Tait Shanafelt
Pages 863 – 864
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Incidental findings on follow-up fluorodeoxyglucose positron emission tomography studies in lymphoma patients: beware the outlier
Nicolas Aide;  Louis Irving; Rodney J. Hicks
Pages 865 – 867
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Discontinuing imatinib in chronic myeloid leukemia: don't try this at home
Ryan Mattison; Richard A. Larson
Pages 868 – 870
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Deletion of the der(9q) in chronic myeloid leukemia: the controversy continues
Lucy A. Godley
Pages 871 – 872
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Reviews
Molecular mechanisms of resistance to Rituximab and pharmacologic strategies for its circumvention
Claudia Stolz; Martin Schuler
Pages 873 – 885
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Immunotherapy of lymphoma and leukemia with T-cell engaging BiTE antibody blinatumomab
Dirk Nagorsen;  Ralf Bargou;  Dominik Rüttinger;  Peter Kufer;  Patrick A. Baeuerle; Gerhard Zugmaier
Pages 886 – 891
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Original Article: Clinical
A combination of rituximab, cyclophosphamide and dexamethasone effectively treats immune cytopenias of chronic lymphocytic leukemia
Matthew Kaufman;  Sewanti A. Limaye;  Nancy Driscoll;  Christina Johnson;  Angelica Caramanica;  Yehuda Lebowicz;  Dilip Patel;  Nina Kohn; Kanti Rai
Pages 892 – 899
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Does a diffuse growth pattern predict for survival in patients with low-grade follicular lymphoma?
Sharathkumar Bhagavathi;  Keni Gu;  Fausto R. Loberiza;  Martin Bast;  Julie M. Vose; Dennis D. Weisenburger
Pages 900 – 903
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
[18F]-fluorodeoxyglucose positron emission tomography combined with computed tomography detection of asymptomatic late pulmonary toxicity in patients with non-Hodgkin lymphoma treated with rituximab-containing chemotherapy
Dimitrios Kalkanis;  Alexandra Stefanovic;  Fabio Paes;  Maricer P. Escalon;  Aldo Serafini; Izidore S. Lossos
Pages 904 – 911
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma
Mehmet Kantar;  Buket Kosova;  Nazan Cetingul;  Sevinc Gumus;  Ertug Toroslu;  Nur Zafer;  Nejat Topcuoglu;  Serap Aksoylar;  Mehtap Cinar;  Asli Tetik; Zuhal Eroglu
Pages 912 – 917
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Clinicopathologic features and treatment outcome of non-Hodgkin lymphoma of the breast – a review of 42 primary and secondary cases in Taiwanese patients
Yu-Chin Lin;  Chung-Hsin Tsai;  Jia-Shing Wu;  Chiun-Sheng Huang;  Sung-Hsin Kuo;  Chung-Wu Lin; Ann-Lii Cheng
Pages 918 – 924
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Early stage gastric diffuse large B-cell lymphomas: results of a randomised trial comparing chemotherapy alone versus chemotherapy + involved field radiotherapy
Giovanni Martinelli;  Federica Gigli;  Liliana Calabrese;  Pier Francesco Ferrucci;  Emanuele Zucca;  Cristiano Crosta;  Giancarlo Pruneri;  Lorenzo Preda;  Gaia Piperno;  Mary Gospodarowicz;  Francesco Cavalli; Henry Moreno Gomez
Pages 925 – 931
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
A unique case of B cell lymphoma relapsing as CD4/CD56 blastic neoplasm
Wing Y. Au;  Kai Y. Wong;  Thomas S. Wan;  Jason C. So;  Gopesh Srivastava; Raymond Liang
Pages 932 – 936
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis
Graham W. Slack;  Judith A. Ferry;  Robert P. Hasserjian;  Aliyah R. Sohani;  Janina A. Longtine;  Nancy L. Harris; Lawrence R. Zukerberg
Pages 937 – 943
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Previous best responses can be re-achieved by resumption after imatinib discontinuation in patients with chronic myeloid leukemia: implication for intermittent imatinib therapy
Hyun-Gyung Goh;  Yoo-Jin Kim;  Dong-Wook Kim MD, PhD;  Hyeoung-Joon Kim;  Soo-Hyun Kim;  Se-Eun Jang;  Jeong Lee;  Dongho Kim;  Wan-Seok Kim;  Sa-Hee Park; Il-Young Kweon
Pages 944 – 951
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Karyotype changes during long-term targeted therapy of chronic myeloid leukemia with imatinib
Barbara Pieńkowska-Grela;  Jolanta Rygier;  Renata Woroniecka;  Beata Grygalewicz;  Anna Pastwińska;  Paulina Krawczyk;  Bernadeta Ceglerek;  Ilona Seferyńska;  Anna Sikorska; Lech Konopka
Pages 952 – 965
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Original Article: Research
Multiple myeloma cells undergo differentiation upon exposure to rosiglitazone and all-trans retinoic acid
Haiwen Huang;  Depei Wu;  Jinxiang Fu; Guanghua Chen
Pages 966 – 973
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Dysregulation of unfolded protein response partially underlies proapoptotic activity of bortezomib in multiple myeloma cells
Hongjuan Dong;  Liang Chen;  Xiequn Chen;  Hongtao Gu;  Guangxun Gao;  Ying Gao; Baoxia Dong
Pages 974 – 984
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
select-up

Privacy Policy | Terms & Conditions | Accessibility | RSS
FAQs in: English . Français . Español . 中文（简体和繁體）
© 2009 Informa plc